Data gathered: November 27
Alternative Data for Catalent
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 353 | Sign up | Sign up | Sign up |
| Sentiment | 50 | Sign up | Sign up | Sign up |
| Webpage traffic | 205,000 | Sign up | Sign up | Sign up |
| Employee Rating | 60 | Sign up | Sign up | Sign up |
| Google Trends | 32 | Sign up | Sign up | Sign up |
| Patents | 28 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 137 | Sign up | Sign up | Sign up |
| Facebook Followers | 13,096 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,461 | Sign up | Sign up | Sign up |
| Twitter Followers | 19,346 | Sign up | Sign up | Sign up |
| Twitter Mentions | 24 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 7,420 | Sign up | Sign up | Sign up |
| News Mentions | 3 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 32 | Sign up | Sign up | Sign up |
| Linkedin Employees | 13,872 | Sign up | Sign up | Sign up |
About Catalent
Catalent, Inc. is a holding company, which engages in the provision of delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. It operates through the following segments: Softgel Technologies; Biologics and Specialty Drug Delivery; Oral Drug Delivery; and Clinical Supply Services.
| Price | $61.00 |
| Target Price | Sign up |
| Volume | 1,090,000 |
| Market Cap | $11.1B |
| Year Range | $53.58 - $61.29 |
| Dividend Yield | 0% |
| PE Ratio | 209.17 |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
Catalent, Inc. (NYSE:CTLT) Shares Acquired by Charles Schwab Investment Management Inc.November 27 - ETF Daily News |
|
First Horizon Advisors Inc. Has $27,000 Stock Holdings in Catalent, Inc. (NYSE:CTLT)November 26 - ETF Daily News |
|
B. Metzler seel. Sohn & Co. Holding AG Makes New Investment in Catalent, Inc. (NYSE:CTLT)November 26 - ETF Daily News |
|
Victory Capital Management Inc. Sells 1,172 Shares of Catalent, Inc. (NYSE:CTLT)November 26 - ETF Daily News |
 |
Catalent (NYSE:CTLT) Cut to “Sell” at StockNews.comNovember 25 - ETF Daily News |
EU antitrust regulators set to okay $16.5 billion Novo Holdings, Catalent deal, source saysNovember 21 - Finnhub |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '24 | 0 | 0 | 0 | -17M | 0 | |
| Q3 '24 | 1.02B | 842M | 181M | -129M | -1M | -0.130 |
| Q2 '24 | 1.3B | 917M | 384M | 23M | 181M | 0.650 |
| Q1 '24 | 1.07B | 845M | 229M | -101M | 44M | -0.060 |
| Q4 '23 | 1.02B | 853M | 171M | -206M | -57M | -0.240 |
Insider Transactions View All
| Ryan Michelle R filed to sell 10,835 shares at $59.7. November 14 '24 |
| Ferraro Joseph Anthony filed to sell 23,967 shares at $60. October 21 '24 |
| McErlane David filed to sell 36,304 shares at $60. September 27 '24 |
| Ferraro Joseph Anthony filed to sell 24,287 shares at $59.6. August 5 '24 |
| Gunther Scott filed to sell 39,635 shares at $59.6. August 5 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
Jun 5, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
May 6, 24 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Jun 12, 23 | Sell | $1K - $15K |
Read more about Catalent (CTLT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Catalent?
The Market Cap of Catalent is $11.1B.
What is Catalent's PE Ratio?
As of today, Catalent's PE (Price to Earnings) ratio is 209.17.
What is the current stock price of Catalent?
Currently, the price of one share of Catalent stock is $61.00.
How can I analyze the CTLT stock price chart for investment decisions?
The CTLT stock price chart above provides a comprehensive visual representation of Catalent's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Catalent shares. Our platform offers an up-to-date CTLT stock price chart, along with technical data analysis and alternative data insights.
Does CTLT offer dividends to its shareholders?
As of our latest update, Catalent (CTLT) does not offer dividends to its shareholders. Investors interested in Catalent should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Catalent?
Some of the similar stocks of Catalent are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.